In vitro and in vivo assessments demonstrate Bacillus coagulans MR-1B's effectiveness against Vibrio parahaemolyticus, suggesting a viable solution for aquaculture.
The global Macrobrachium rosenbergii aquaculture industry is plagued by Vibrio parahaemolyticus-induced diseases. Antibiotic overuse further exacerbates antimicrobial resistance and ecological hazards, creating an urgent need for eco-friendly control strategies. In this study, Bacillus coagulans mr-1B was isolated from the hindgut of healthy M. rosenbergii to evaluate its probiotic potential. The strain was identified via 16 S rDNA sequencing, with its genomic characteristics analyzed using Nanopore-Illumina hybrid whole-genome sequencing. Its efficacy was validated through in vitro assays (tolerance to high temperature, acid, and bile salts; biofilm inhibition) and in vivo challenge tests. Results showed that mr-1B harbors biosynthetic gene clusters for antimicrobial metabolites. It retained 26.4% survival at 90 °C and 60.1% survival at pH 3.0, and effectively disrupts mature V. parahaemolyticus biofilms. After V. parahaemolyticus challenge, the 14-day mortality of M. rosenbergii fed with mr-1B was only 9% (vs. 92% in the positive control), with no safety risks. In conclusion, B. coagulans mr-1B exhibits excellent anti-Vibrio activity and stress tolerance, serving as a promising probiotic candidate for green control of vibriosis in M. rosenbergii aquaculture, which aligns with the demands of green aquaculture.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: